All right, we'll get started here. Welcome everyone to day three of the Stephens 2026 Annual Investment Conference, live and in person in Nashville. I'm Raj Kumar, Healthcare Services Analyst with Stephens. This morning, we have PACS Group, a leading provider of skilled nursing care across the U.S. Joining us from PACS today are Carey Hendrickson, Chief Financial Officer, Josh Jergensen, President and COO, and we have Ryan Welch in the audience as well, who's Director of Corporate Finance. I want to thank the team for joining us here today at our conference, and I think we'll jump right into Q&A if that's good with y'all.
Awesome. Thank you, Raj. Appreciate the opportunity to be here.
Awesome. Maybe to kick off the conversation, we've kind of asked all of our companies of this, but we're kind of starting to close out 2026. Would it be helpful to kind of go through a year in review and kind of in your mind and how 2026 have played out operationally relative to kind of your initial expectations heading into the year?
Yeah. Maybe I'll start.
You start and I'llā
Carey can share as well. 2026 has been a landmark year for us. 2025 was an interesting year for PACS, to say the least. We were incredibly encouraged by the way as we kind of closed out 2025 and were able to get our financials back on file. I think people were really excited, and we were excited to share the story of what had gone on in 2025. We felt that there was a tremendous amount of momentum that we had built up to that period of time. We had a hungry group of people excited to prove what we were capable of doing from a clinical and financial perspective in our space. We carried that momentum incredibly well into 2026. We've had an exceptional year.
We were able to report our third quarter earnings. We started to report on some same-store metrics and to see how our same-store has improved revenue up, skilled mix and occupancy up. It's great to see our existing platform do well. Maybe the thing we're most excited about is where 2025 was a bit of a down year from a growth perspective for a variety of different reasons, we've been able to add 78 additional facilities here in the last couple of months. Maybe a little slow acquisition from we were working on some of those big deals through the course of the entire year. To be able to close that up and kind of refill that new bucket in our cohort is really exciting for us.
Yeah, the only other thing I'd add is, look, as we went into this year, we thought it was going to be a really good year. We really did. We thought our range for EBITDA at the beginning of the year, the midpoint of that range was $565 million, and we've been able to beat and raise our guidance throughout the year so that now we're at $690 million as a midpoint. We thought going into the year we'd be at $565 million. That's incredible improvement from even where we thought we'd be. It's a 37% increase over where we were in 2025. So, this has been a year of tremendous growth. The good news is that we continue to believe that we can do that going forward.
Great. Maybe kind of setting the table broadly for 2027. I know you guys haven't given out formal financial guidance yet, but as we kind of think about some of the puts and takes, what should we keep top of mind? Maybe kind of thinking about the platform more specifically, Josh, you highlighted the kind of the same facility bucket. Would it be helpful to also kind of talk about how many of the non-same facilities kind of enter into the same facility comp?
Yeah. So, we have currently for 2026ā for this year, we have 284 facilities that are in our same store. We'll just have six more add in next year, so we'll have 290. But pretty similar numbers. We look at the cohorts, new, ramping, and mature. We'll have about the same number in the ramp. So we have 78 ramping. I think this year we'll have maybe 82 or 83 in ramping and new, a few new in there as well this year. But pretty relatively the same number. So we expect our organic growth rates on that same store to continue to be in the mid-single digits. We were at 6.4% growth in the third quarter. It's been about 6%, 6.1% on average for the first nine months of the year. And we think we can continue that into next year.
Then we've got the new embedded growth that's related to the 78 new facilities that we brought on this year. So, we feel like we're in a really good position for growth as we go into 2027. We do talk about some puts and takes. We did have some WQIP money that we got this year from California, which is in quality incentive payments based on the level of quality that we provide in the markets. So, we had sixā a total of $20 million or so dollars in net EBITDA impact from California WQIP. Then we had $5 million that we noted in our recent earnings release related to some retroactive Ohio quality incentive payments. So, you've got those things that won't happen next year. We do expect probably one more California payment to be made in 2027 that may be $15 million-$20 million.
So, they might be a little bit offsetting. Those are some of the things that are, I guess, unusual in the earnings.
Got it. As we kind of think about, clearly there's a lot of local influences in the facility performance. This is a predominantly Medicaid business, and as you kind of think about the midterms and kind of the changes that have happened, even at the state level, particularly Texas, where you've kind of done a good amount of M&A this year. How do you feel about that kind of backdrop from a reimbursement perspective, a policy perspective, and maybe kind of talk to the headwind, tailwinds as you kind of see from maybe your kind of regulatory partners?
Yeah, maybe I can start with that. We always are trying to build relationships and help legislators understand just how important skilled nursing is. I think together with the American Health Care Association, which is our trade association, we've done a really great job lobbying and educating people on how important skilled nursing is, regardless of what side of the aisle you sit on. We constantly battle what we often talk about, kind of the reimbursement environment and the regulatory environment. Different sides of the aisle usually kind of are more engaged and handle those two separate issues in different ways. That's why it's important for us with changing administrations and what we just saw happen to have relationships on both sides. I can share with you, we do. We have some really great relationships. One of the things that I'll share is we look at reimbursement.
We've been operating and we've been able to, particularly post-COVID, educate people, particularly at the state level, to understand how important it is to fund the Medicaid program to skilled nursing. They're realizing that the acute care environment is an expensive place to take care of patients. A really good option, if you can do it well, is a post-acute setting, from an institutional perspective, is skilled nursing. That has been something we've emphasized and we've started to see even in recent bills where we were carved out of some of the provider tax cuts and other things from a skilled nursing perspective that became really beneficial. So the rate environment's been pretty good. The regulatory environment, we were able to defeat the staffing mandate and some other things.
There is naturally going to be some of this give and take and a pull or push in particular areas. But one of the things that we pride ourselves on is this industry is already really heavily regulated. Sometimes we kind of joke internally, "How much more regulated could you actually make it?" There are ways to do that, but we are accustomed to working in that environment. When we look at where we spend a lot of our time, it is making sure that we are fighting for the appropriate reimbursement to cover the expenses associated with doing a really great job caring for our patients.
If there were any way to have it swing, if we got slightly more regulated, but those programs were funded, which is typically what happens in a kind of a Democratic-led House and Senate, then those are usually good operating. Those have been good years in skilled nursing, and we think those years will continue to be positive looking forward.
Great. Maybe I will pause to see if we have any questions from the audience.
Maybe just quickly, do you prefer one political party over the other to be in power, or is it kind of pretty agnostic?
No, I wouldn't say that. It's difficult to kind of side one way or the other because there's pros and cons of both. Fortunately, we've actually had, and I've sat at dinners or lunches where you've had people from both sides of the aisle. One thing I think that is happening is people are understanding how important healthcare is, which I think has existed for a while, but they're particularly starting to understand how important and impactful post-acute care can be, regardless of whether you're Republican or you're Democrat. For us, it's important establishing relationships, so we don't have a preference. We just want people who are open to hearing what we can do to help the space as a whole, to help the flow of patients, to help reduce cost to the system.
Again, I think we've had some good success in being able to educate people on that. Shockingly, not a lot of people know a lot about nursing homes when they're running for political office, and we've had to educate them on that.
Great. Thank you.
Great. I think when we think about PACS and kind of looking at the kind of operating performance and financial performance that's kind of been printed since IPO, there's a clear step up and acceleration across all the pillars, whether it be organic or even M&A. One component of PACS, I know there's a very locally driven model, but the service that the, quote unquote, "service center" provides is also kind of very important on connecting all the pieces together. I guess as you kind of expanded and accelerated this expansion, can you talk about the kind of ongoing investments that you made at the service center, kind of overall support the kind of type of growth that you've done year to date and potentially hope to do kind of long term?
Yeah. One of them's sitting right here to the left of me, Carey's the new CFO, and I'll let him weigh in. But one of the things that is important, as you acknowledge, and I'll call it a non-negotiable for us, is our operating model. We really believe that healthcare is local, particularly at a post-acute level. And the ability for our operators to have the information that they need in real time to be able to make good decisions closest to the patient, closest to the communities that they're serving. So providing them that autonomy is important. Having an infrastructure that's built to be able to support those local operators to, again, provide them those tools, to create guardrails, to create things that allow them to focus the majority of their time on patients and patient care is important.
We have increased the quality of that support and the amount of that support significantly. I've been here at PACS my entire career, so I've got to see some of these changes as they've navigated. We've added some people, like Carey in the CFO role. We have a new chief legal officer. We've made some restructuring in some of the other departments. We have a new chief compliance officer who is incredible, who has experience in our space. We really have ramped up the level of experience and expertise, and then in turn, those individuals have come in and been able to scale and grow their own teams. So our compliance department looks a whole lot different than it did before, and it's full of resources that our chief compliance officer had worked with before.
And it's allowed us to grow and to scale, and again, sitting and working in the service center myself and having been there for the majority of my career, I can say that we're at a stronger point than we've ever been historically, both with the personnel and the amount of resources that we're dedicating.
Yeah, and I would just say the team showed really, really well most recently with the acquisitions we've made. The 34 Eduro facilities, the 32 that we did in Florida. The ease with which the integrations took place was really impressive. Our teams did a great job, and it was really very seamless. When we add new acquisitions, we're at a point now where we don't have to add very many new people when we add acquisitions. There may be an additional accountant we need here and there, but at the services level, there are really not that many adds we need to make at this point. We'll grow a little bit as the business continues to grow, but we're in a pretty good place.
Got it. I think M&A is a very important part of the platform in terms of spreading the PACS model to drive overall quality of care in the nursing home and post-acute care setting. Carey, you spoke to this earlier, when you initially put guidance out and now where it is now for EBITDA, it has been a 37% increase since 2025. As we think about, hey, what if you guys did not do any M&A? What is the embedded earnings power of the business?
Yeah.
How many years of runway do you have to sustain double-digit earnings growth if you just shut off M&A?
Yeah. Well, we have a lot of embedded opportunity. Really, these 78 that we have done most in the last few months has created a lot of additional embedded opportunity because those today have, I would say, all collectively together, very minimal EBITDA today. We know we are going to get them to a significant amount of EBITDA going forward. I do not like to put a number on it and say, "This is the embedded opportunity," but it is very significant, even with the operations that we have today.
First of all, the spigot is not going to shut off because we are going to continue to do acquisitions. If it did, we would still have a significant amount of growth just with the operations we have today. That is one of the things that I think people recognize, but I do not think they think about it as much.
There is an incredible opportunity just with our existing operations for continued growth. I talked about the organic growth, I think will continue to be in the just from same-store, but then you have got the growth that is going to happen outside of the same-store because that is about 290 of our almost 400 facilities. You still got 110 there that are in the relatively new and ramping phases that are continuing to grow as well. We are going to be in the double digits for a while going forward.
Got it. Maybe turning to the same-store bucket, clearly it is the portfolio that helps sustain or provide a mid-single-digit earnings floor. It would be helpful to maybe parse out, because not all facilities operate equally, so it is like as we think about that mid-single digits, any way of breaking down the upper quartile versus lower quartile from an occupancy or skilled mix perspective, just within the same-store bucket?
Within the same store? Well, within the same store, we have 284, I believe now, about 80 of those, somewhere around 80 of those are in the ramping phase, which would be, they would have occupancy that are mid-80s, margins that are in the mid to high single digits kinds of margins. They are still moving towards this mature phase. The mature facilities that are inside that same store at about 93% occupancy and a low to mid-teens operating margin. But even within the mature facilities, there is going to be continued growth there. I mean, 93% occupancy and a 30% skilled mix is not the goal. The goal is 100% occupancy, 100% skilled mix. We have some facilities who are at those levels.
That is the goal, just because they are at 93%, especially with the demographic tailwinds that we have, I think we are going to continue to see occupancy push forward in that mature facility cohort. So, as I said, there is still a lot of opportunity even inside the same store for that mid-single-digit growth.
Got it. I know we talk about these different buckets, really from a reporting standpoint, the only thing that distinguishes them is just time, right?
Right. Uh-huh.
In terms of the portfolio. But would love to dive deeper in terms of, what are the qualitative factors in terms of maybe leadership tenure, clinical capabilities, maybe local relationships with referral partners, or even just the community itself? How does that play into distinguishing other than just time in the market?
Yeah. It is a really great question. You actually identified a number of those things that exist. I mean, the first, and we talk about it all the time, our operating model really is different because we believe in empowering the local person and having someone in the administrator role that is capable to build a team, to run a business, to understand what is most important, that can deliver on our product, which is care, at a very high level together with their teams, so that virtuous cycle of patients and patient flow and relationships actually matter. So we start there with the people. As the facilities have more time, their leadership and their team get to continue to work together for a long period of time.
The confidence that they have in themselves and in each other, the ability to get a little more ambitious through training and education on clinical capabilities, to take a patient that maybe a year or two ago you would not take because it was too clinically complex. Doing that, gaining the confidence as a team to be able to do that successfully, and having that play out in an actual community understanding, both from a referral, an acute care hospital that may be referring, or a family that is looking reputationally at the facility, what can they do? How can they benefit us as a downstream provider? Is this some place I would like to take my mom or my dad to receive care? As that has a chance to play itself out over time, all those things increase.
We're able to sit down with managed care providers that maybe historically want to give you a certain discount on a fee-for-service rate. But if you have bed capacity and density in an area, if you've proven to have lower rehospitalization rates because the care and quality is better, their willingness to contract not only at a higher rate, but to drive higher volumes of patients. We have managed care providers who start putting nurse practitioners or physicians that are assigned only to our facilities. That usually happens more in the maturity phase than it does in a new acquisition that we've taken on that's distressed. There's a reason that it's distressed. As that model plays out over time, we didn't just create those timelines just out of thin air.
It was based on the track record and history and the numbers that show when it reaches three years in a market with good leaders, good teams, good clinical capabilities and systems, maybe a reinvestment into the physical plant, that usually yields certain KPIs that in turn turn into a successful EBITDA margin for us. The longer that goes even beyond three years, three years isn't like the cutoff where it's like, "Congratulations, you've made it. You're at three years, and now you've maxed out." Some of the facilities that we've had for 10 or 12 years are reaching those higher capacities of closer to 100% and a much higher skilled mix because the community trusts them.
Got it. Yeah, maybe just on those facilities that are reaching a certain threshold, maybe kind of, I know you've spoken to kind of real estate ownership being an important pillar for the more mature facilities. I think Jason had previously kind of alluded to a 50/50 mix, but I think he said it sounded as a good number. As you kind of think about the real estate strategy, the lease kind of buyback ability, and the ability to maybe add existing beds to those mature facilities that you have real estate ownership of, maybe kind of help us kind of think about the opportunities there, and maybe what is the kind of occupancy threshold that you might start even considering to kind of add a maybe new wing to an existing operation?
Yeah. Each state is a little bit different. At times, there's a CON, a certificate of need state, where getting licensed beds is difficult. Sometimes those beds will come. We have one where we're going to transact on some beds where we're going to have an opportunity to do an expansion to a facility. Those situations are unique. We're not necessarily counting on them. Usually what we're doing within the walls and confines of the facility is playing around with the ability to take more acuity, more skilled mix within the beds that we currently have available. When those opportunities present itself, we will take advantage of those. From a real estate perspective, we are trying.
When we first started out as a company, we were using the majority of our capital, which was small at the time, to reinvest in our own operations, to use as working capital to keep the facilities and the operations of the facilities afloat. The free cash flow to use on real estate at the beginning wasn't there. Now that we have more of that, we're looking for real estate opportunities, but we aren't going to box ourselves in to only looking for those opportunities that come with real estate. The acquisition in Florida, 32 facilities was a REIT [inaudible]. The real estate was not on the table, not even through a purchase option, which oftentimes we try and negotiate and have been successful in negotiating. We didn't want to forego that opportunity to enter that market for a variety of reasons.
The cash flow that comes from the improved operations, but also the fact that it plants a flag in a new state, which allows other onesie, twosie, smaller acquisitions that may include real estate to become available to us. I think initially that 50/50 mark would have been a nice one to have a goal to. Again, we're not going to box ourselves into that and pass up on lease opportunities that are good ones in order to simply try and hit that ratio of real estate acquisition.
Got it. You touched on skilled mix in terms of optimizing that and taking on more high acuity care. Maybe what's the, as we think about what pushes it beyond, I think the previous high watermark was during COVID, where there was some waivers and expansion programs in place that helped put people in skilled nursing and away from the acute care setting to relieve some of their capacity pressures. But maybe what's the core tenet there? Is it more just referral relationships and partnerships, those maturations, or is it from a payer perspective? Maybe help us think about how skill mix can, I think, high 20s, 29% skilled mix in your mature bucket.
What does that kind of look like to get to like 30%, low 30s?
Well, COVID was an interesting time, and to use that as a benchmark would be very difficult to do. There was a need essentially to try and keep a more clinically acute patient in your facility rather than clogging up the hospitals. I don't necessarily anticipate, nor would I wish to have another period of timeā
Yeah.
ālike that. So using that as a benchmark, we don't. We're looking for kind of the basic blocking and tackling traditional patients that we see being referred. Again, often opportunities that we have where hospitals are saying, "Hey, we have this sort of clinical acuity that we oftentimes are keeping five or six days in a hospital. We'd really like that to get that down to two or three, but we need you to have the capabilities to provide for these patients." So much like I talked about earlier in the question that you asked about, what creates the facility success, that tenure, that team that's being there? The ability to roll out clinical programs certainly helps, and it helps on all fronts.
It helps not only with the traditional referrals that you're receiving, that increase skilled mix, but certainly it gives us a seat at the table with managed care providers. When we go into a new acquisition, oftentimes we either don't have contracts or contracts potentially can be canceled or tried to be renegotiated, and they want to see that star ratings and other things, the capabilities, the metrics that they look at and are either incentivized or disincentivized with, rehospitalization rates and other things, are such that they can count on the provider. And when they can count on you, they want to contract with you. They want to do it in larger amounts of volumes, and they're generally willing to do it for higher dollar amounts. And we're seeing that.
When Carey references these numbers about kind of same-store or mature facilities that continue to see progress, it is because of that. It is usually moving the needle that. It is not building additional beds. It is not doing some of those things. It is simply kind of doubling down on the ability to do what we do, which is care for patients in an incredibly high level with great outcomes, and having that virtuous cycle return higher volume of patients to us.
Got it. Maybe kind of looking at Florida as the case study here, it is a new state, new market for PACS, but you have worked with these payers across different states, the nationals that are there. Maybe kind of talk about, are you starting from square one from a contracting standpoint? Is there some kind of goodwill that kind of gets you into the door quicker from a rate perspective? Or is it kind of you still have to kind of just grind it out and build out that relationship, despite the other side of the party knowing who you guys are.
Yeah. It is really nice to have relationships. With 400 facilities, every large managed care provider we have met, generally a high-ranking executive or somebody that is key in the contracting, each of those is generally handled locally.
The opinion of those local market leads and contracting agents, although they may have heard of PACS, they are the ones in Florida contracting, and the facilities we have just taken over do not have the reputation that is a good one. So, it probably gets us a foot in the door. It gets us a seat at the table to sit down and talk about what we have historically been able to do. We have already begun to have some of those conversations, and we will continue to have some. So, that helps. But we truly do need every individual facility, local facility, to win out in quality metrics, to win out in care. Star ranking is usually kind of the initial gating item that a managed care organization needs.
Even though PACS is PACS, and we point to our mature facilities, and we have nearly 80% of our facilities that have four- and five-star ratings, they oftentimes ask the question, "Well, the one facility I'm contracting with in Florida has a one or a two." Our goal is to change that, and we have to. The density matters a lot as part of our strategy that's existed, and it usually takes and has a bigger impact as we move throughout kind of the new and ramping where maybe because of our scale, we're getting a contract at the end of the new beginning of ramping period, where historically we weren't getting that until we were able to prove out success over longer periods of time.
We start to cut down those windows of time that it would normally take to start seeing some of those KPIs move. I anticipate that being the impact that probably in Texas and Florida in these new acquisitions that we'll have. But we still have to perform at that individualā
Yeah.
ālocal level, and that's where we've thrived and had success in operating.
Got it. I think, yeah, we talked about kind of Medicare reimbursement, PDPM. I think on the Medicaid side, I think some states are also trying to implement their own version of PDPM. Think about Ohio, Texas, Florida, Tennessee. How meaningful could those mechanisms kind of be beneficial to the patient base that you guys are looking to serve? Maybe kind of any implications on timeline of when those kind of get into place?
Yeah. If there's a program that reimburses for quality or acuity, we are raising our hands. We're the first ones to raise our hands. And there's many providers who don't want that. They'd rather have just a cost reporting schedule.
In fact, there's active conversations in California about how they're going to kind of reset rates and structure and the quality programs and other things that are associated with it. We're going to provide that's going to raise our hands and sit at the table and say, "We'd like it to look a lot more like Kentucky and Ohio and Tennessee, where there's a component related to cost, but there's a component related to actually how are you performing with the patients that you're taking, and how acute are those patients?" If they're more acute than others, you should be reimbursed slightly higher for that. That's why we targeted some of those states that we did. Tennessee was severely distressed, and we knew that because there was a CMI, the case mix index component of the Medicaid rate, that we would have an ability with time to effect change.
We're already trending to be one of the leaders, if not the leader, in that state in the amount of acuity we're taking and the quality in which we're providing care to those patients, both there and in Ohio and other states. We already lead out in the state of Kentucky in regard to that. As those opportunities present themselves again, as you have new legislators, as you have new governors, or you have established governors that you get a chance to spend some time with and educate on what matters and what can be impactful from a reimbursement perspective, we're going to lead out in those conversations, and we're going to push for quality and for acuity, because that's historically what we've had a lot of success doing.
It is really what the industry should be held accountable to, the ability to take an acute patient and to do it at an incredibly high level.
Got it. You touched on California. Clearly, new Governor in place, Becerra, former HHS secretary under Biden. I do not think he was the key driver of the federal staffing rule, but it was under his administration. He is also a big supporter of Medi-Cal, the Medicaid program in California. What conversations have you had with him, and where is he looking to make changes? I know there is the general rooting out the fraud, waste, and abuse. As we think about WQIP, does he look to reinstate something similar? Just curious on how those conversations have been going in California, since it is such a big state for PACS.
Yeah. So, I have an operations leader, our Senior Vice President of Operations over California, who has had a lot of productive conversations with Governor Becerra. We actually are part of a labor management coalition with SEIU, which also has a great relationship with the Governor's office and Governor Becerra. We partner really well with the unions. We have some organized labor, a good amount of it in the State of California, have a great relationship with them. So, helping, again, educate someone like Governor Becerra on the details associated with the Medicaid program, how it impacts skilled nursing, what programs should be considered, why quality should matter to him, why outcomes and acuity should matter. If you are taking behavioral-based patients, those are oftentimes harder to take care of. There should be reimbursement associated with that.
Up to this point, I know there have been initial conversation, but Governor Becerra has been a great listener and has been willing to understand where we are at and knows that it is a program that needs to be addressed and has shown all the signs that you would hope to see at this point of a willing person to understand that there is a need and how can we best address that need and listening to providers who are actually on the ground doing it. As the largest provider in California, we are going to be very active in those conversations.
Got it. I guess, as we come up on time, maybe just one last one as we kind of think about the PACS story. I think we've touched upon this too, just on the general earnings power of the business. But what do you think is kind of still kind of under the radar from a maybe investor perspective that might not be truly appreciated as we kind of think about the earnings power as a business over the next three to five years?
Well, we alluded to it earlier, and that is just the embedded opportunity that's in our portfolio today. There's just so much more growth that's out there. Even one thing I think people look at, that 93% occupancy for our mature facilities and the 31% or so of skilled mix, and they think, "Okay, well, you can't go any higher than that." We actually can go higher than that, and we expect continued improvement and continued further financial results from that cohort, that mature cohort, especially with the tailwinds that are coming related to demographics and then just the quality of our operations. I think that's something that may be underappreciated a bit. Josh?
Yeah, I would just point to something that we do talk about a lot, but I sometimes wish that people could see the level of talent that PACS is bringing to an industry that quite frankly, for a long period of time, didn't attract the talent that would be required to run what is a complicated business. Having been a nursing home administrator, it's difficult. You're managing a whole lot of things underneath the roof, not only employees, but processes, and you're feeding meals, and you're housing people, and you're providing care, and you have physicians that come in occasionally, not all the time like they are in a hospital.
Managing that environment is difficult. The quality of leadership, we get together annually for a leadership summit, and looking across that room of the talent that we've attracted to the organization, having a depth of talent not only in our facilities, but in the training program. Forward-thinking people also, as we talk about AI is going to have an impact on our space, and we're learning a lot about how it's going to in some ways for efficiency.
We're bringing up a generation that understands that world pretty well and the use cases for it and what's going to matter. We're very forward-thinking as an organization. We have great, young, energetic talent that cares about this business. Sometimes it's difficult to see that because you see numbers naturally and not necessarily the ground level. As a person responsible for operations, I get to roll up my sleeves and get involved. We have an incredibly strong platform with really excellent people, and the future, we feel, is incredibly bright.
Great. Well, I think that puts us at time. Thank you for joining us here today.
Thank you very much.
Thanks, Josh. Appreciate it.
Good to see you, Raj.